Endoscopy 2005; 37(5): 425-433
DOI: 10.1055/s-2005-861294
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Prospective Study of the Effectiveness of Percutaneous Transhepatic Photodynamic Therapy for Advanced Bile Duct Cancer and the Role of Intraductal Ultrasonography in Response Assessment

C.  S.  Shim1 , Y.  K.  Cheon1 , S.  W.  Cha1 , S.  Bhandari1 , J.  H.  Moon1 , Y.  D.  Cho1 , Y.  S.  Kim1 , L.  S.  Lee1 , M.  S.  Lee1 , B.  S.  Kim1
  • 1Institute for Digestive Research and Digestive Disease Center, Soon Chun Hyang University College of Medicine, Seoul, Korea
Further Information

Publication History

Submitted 8 October 2004

Accepted after Revision 16 November 2004

Publication Date:
20 April 2005 (online)

Background and Study Aims: We evaluated the therapeutic effects of percutaneous transhepatic photodynamic therapy (PDT) in patients with advanced bile duct cancer. The utility of intraductal ultrasonography (IDUS) for the assessment of responses and for regular follow up after PDT was also examined.
Methods: Percutaneous transhepatic biliary drainage (PTBD) was initiated before PDT. Following dilation and maturation of the PTBD tract, percutaneous PDT was performed. Intraluminal photoactivation was carried out using percutaneous cholangioscopy 2 days after intravenous application of a hematoporphyrin derivative. All patients were additionally provided with percutaneous bile duct drainage catheters after PDT. IDUS was conducted monthly to measure the thickness of the tumor mass before and after PDT.
Results: 24 patients with advanced cholangiocarcinomas (Bismuth IIIa, n = 4; IIIb, n = 10; IV, n = 10) were treated with PDT. At 3 months after PDT, the mean thickness of the tumor mass had decreased from 8.7 ± 3.7 mm to 5.8 ± 2.0 mm (P < 0.01). At 4 months after PDT, the thickness of the mass had increased to 7.0 ± 3.7 mm. Quality of life indices improved dramatically and remained stable 1 month after PDT; the Karnofsky index increased from 39.1 ± 11.36 to 58.2 ± 22.72 points (P = 0.003). The 30-day mortality rate was 0 %, and the median survival time was 558 ± 178.8 days (current range 62 - 810 days).
Conclusions: PDT using percutaneous cholangioscopy is safe and effective for advanced hilar cholangiocarcinoma, and seems to prolong survival. IDUS is useful for evaluating changes in the thickness of the tumor mass after PDT.

References

  • 1 Jarnagin W R, Fong Y, DeMatteo R P, Gonen M. et al . Staging, analysis of resectability and outcome in 225 patients with hilar cholangiocarcinoma.  Ann Surg. 2001;  234 507-519
  • 2 Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma.  Ann Surg. 1992;  215 312-318
  • 3 Guthrie C M, Haddock G, De Beaux A C. et al . Changing trends in the management of extrahepatic cholangiocarcinoma.  Br J Surg. 1993;  80 1434-1439
  • 4 Alexander F, Rossi R L, O’Bryan M. et al . Biliary carcinoma - a review of 109 cases.  Am J Surg. 1984;  147 503-509
  • 5 Ortner M A, Liebetruth J, Schreiber S. et al . Photodynamic therapy of nonresectable cholangiocarcinoma.  Gastroenterology. 1998;  114 536-542
  • 6 Berr F, Wiedmann M, Tannapfel A. et al . Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival.  Hepatology. 2000;  31 291-298
  • 7 Nimura Y, Kamiya J. Cholangioscopy.  Endoscopy. 1998;  30 182-188
  • 8 Sato M, Inoue H, Ogawa S. et al . Limitation of percutaneous transhepatic cholangioscopy for the diagnosis of the intramural extension of bile duct carcinoma.  Endoscopy. 1998;  30 281-288
  • 9 Menzel J, Domschke W. Intraductal ultrasonography (IDUS) of the pancreato-biliary duct system. Personal experience and review of literature.  Eur J Ultrasound. 1999;  10 105-115
  • 10 Karnofsky D A, Abelman W H, Craver L F, Burchard J H. The use of nitrogen mustards in the palliative treatment of carcinoma.  Cancer. 1948;  1 634-656
  • 11 WHO .International classification of impairment, disabilities and handicaps. Geneva; World Health Organization 1980
  • 12 Ducreux M, Liguory C, Lefebvre J F. et al . Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors.  Dig Dis Sci. 1992;  37 7787-7783
  • 13 Dowsett J F, Vaira D, Hatfield A R. et al . Endoscopic biliary therapy using the combined percutaneous and endoscopic technique.  Gastroenterology. 1989;  96 1180-1186
  • 14 Chang W H, Kortan P, Haber G B. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage.  Gastrointest Endosc. 1998;  47 354-362
  • 15 Stoker J, Lameris J S, van Blankenstein M. Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction.  Gastrointest Endosc. 1993;  39 43-49
  • 16 Rumalla A, Baron T H, Wang K K. et al . Endoscopic application of photodynamic therapy for cholangiocarcinoma.  Gastrointest Endosc. 2001;  53 500-504
  • 17 Born P, Rösch T, Triptrap A. et al . Long-term results of percutaneous transhepatic biliary drainage for benign and malignant bile duct strictures.  Scand J Gastroenterol. 1998;  33 544-549
  • 18 Born P, Rösch T, Bruhl K. et al . Long-term results of endoscopic and percutaneous transhepatic treatment of benign biliary strictures.  Endoscopy. 1999;  31 725-731
  • 19 Hordijk M L, Kok T C, Wilson J H, Mulder A H. Assessment of response of esophageal carcinoma to induction chemotherapy.  Endoscopy. 1993;  25 592-596
  • 20 Zuccaro G Jr, Rice T W, Goldblum J. et al . Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.  Am J Gastroenterol. 1999;  94 906-912
  • 21 Willis J, Cooper G S, Isenberg G. et al . Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma.  Gastrointest Endosc. 2002;  55 655-661
  • 22 Tamada K, Kanai N, Wada S. et al . Utility and limitations of the intraductal ultrasonography in distinguishing longitudinal cancer extension along the bile duct from inflammatory wall thickening.  Abdom Imaging. 2001;  26 623-631
  • 23 Gress F, Chen Y K, Sherman S. et al . Experience with a catheter-based ultrasound probe in the bile duct and pancreas.  Endoscopy. 1995;  27 178-184
  • 24 Tamada K, Ido K, Ueno N. et al . Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonography.  Am J Gastroenterol. 1995;  90 239-246
  • 25 Tamada K, Ueno N, Ichiyama M. et al . Assessment of pancreatic parenchymal invasion in bile duct cancer by intraductal ultrasonography.  Endoscopy. 1996;  28 492-496
  • 26 Tamada K, Tomiyama T, Ichiyama M. et al . Influence of biliary drainage catheter on bile duct wall thickness as measured by intraductal ultrasonography.  Gastrointest Endosc. 1998;  47 28-33
  • 27 Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage.  Gastrointest Endosc. 1988;  2 95-101
  • 28 Polydorou A A, Cairns S R, Dowsett J F. et al . Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.  Gut. 1991;  32 685-689
  • 29 Evans S, Matthews W, Perry R. et al . Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages.  J Natl Cancer Inst. 1990;  83 34-39
  • 30 Nseyo U O, Whalen R K, Duncan M R. et al . Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report.  Urology. 1990;  36 167-171
  • 31 Shumaker B P, Hetzel F W. Clinical laser photodynamic therapy in the treatment of bladder carcinoma.  Photochem Photobiol. 1987;  46 899-901

C. S. Shim, M. D.

Digestive Disease Center, Soon Chun Hyang University Hospital

657 Hannam-Dong · Yongsan-Ku · Seoul 140-743 · Korea

Fax: +82-2-7491968

Email: schidr@hosp.sch.ac.kr

    >